RL
MindMaze Therapeutics Holding S.A.
RLFTY · OTC
$0.17 -27.38% (-$0.06)
1M -81.17%
Market Cap CHF 22.0M
P/E Ratio -
Div. Yield -
ROE 26.02%
Analýza
AI report o byznysu, financích, ocenění, sentimentu, zprávách a rizicích - napsaný během několika minut.
Piotroski F-Score Weak
1/9Valuation
50 /100
Fair P/B 0.57x
P/S 34.23x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 35.88%
Rev. growth 52.74%
FCF growth N/A
Profitability
20 /100
Weak Net margin 1,542.99%
Op. margin 1,637.85%
FCF margin 1,126.17%
Quality
0 /100
Poor ROE 26.02%
ROA 19.22%
Asset turnover 0.01x
Debt
58 /100
Moderate Current ratio 1.20x
Int. coverage -36.24x
Debt/Equity 0.05x
Stability
1 /100
Unstable Rev. volatility 67.59%
EPS volatility 81.70%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na RLFTY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Zach W. Henderson
Employees
10
Headquarters
Geneva